The anesthetic effects of varying doses of esketamine combined with ciprofol for gastrointestinal endoscopy examinations.
Phase 4
- Conditions
- Gastric disease
- Registration Number
- ChiCTR2400088969
- Lead Sponsor
- Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Eligible patients for gastrointestinal endoscopy are those aged between 18 and 65 years, with no gender restrictions, a body mass index (BMI) ranging from 18 to 28 kg/m², and an American Society of Anesthesiologists (ASA) physical status classification of I or II.
Exclusion Criteria
Patients with severe cardiopulmonary diseases, neurological or psychiatric disorders, those who have taken analgesics within 48 hours prior to surgery, or those with a history of allergy to esketamine or propofol are excluded.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MAP;HR;RR;SPO2;
- Secondary Outcome Measures
Name Time Method Consumption of ciprofol;awakening time;Discharge time;Patient satisfaction;Incidence of cardiopulmonary complications;Incidence of other adverse reactions;